NCT07025330: A Study of Efgartigimod in Patients With IgG4-Related Disease
- State
- Under way
- Phase
- Phase 2
- People
- 5 planned
- Started
- 12 Nov 2025
- Primary completion
- 1 Mar 2028
- Arms
- efgartigimod
- Results
- None posted
- 17 Jun 2025: Trial registered
- 12 Nov 2025: Trial started